eMedevents
  • 142,011+ Medical Conferences
  • 273 Specialties
  • 10,705 Organizers
  • 153,547 Speakers
  • 156 Countries
  • 4,623 Cities
47,337+
CME Conference Registrations Sold
Home  >  Speakers  >  Nicole Ullrich
Nicole Ullrich

Nicole Ullrich

    MD, PhD
Chair, Director, Associate Professor | Boston, Massachusetts    United States of America
Neurology, Oncology
Neurological Sequelae Of Cancer Therapy In ChildrNeuro-fibromatoses.,...More
Spoken at 1 event

Biography :

Nicole J Ullrich, MD, PhD is currently Associate Professor of Neurology at Boston Children’s Hospital, where she serves as Director of Neurologic NeuroOncology at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and as Associate Director and Director of Clinical Trials in the Multidisciplinary Neurofibromatosis Program at Boston Children’s Hospital. She completed her medical and graduate degrees at Yale University followed by residency in Pediatrics and Neurology at Boston Children’s Hospital, where she then did her fellowship in NeuroOncology before joining the faculty.

Her research focuses on neurologic and oncologic complications of NF1 and the long-term neurologic complications of childhood systemic cancer and brain tumors. Dr. Ullrich is Chair of the CNS Late Effects committee, Neuroscience Discipline and Cancer Control/Neurotoxicity committees through the Children’s Oncology Group and is co-chair of the Neurology Task Force of the Long-term Follow up Guidelines for COG.

**********************
************
 
For speaker's contact information - Contact us

Specialties

Neurology, Oncology

Interested Topics

Neurological Sequelae of Cancer Therapy in Children, Neuro-fibromatoses., Neurology, Oncology, Neurofibromatosis, Cancer, Brain Tumors, Clinical Trials

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message